X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cardiovascular (54) 54
cardiac & cardiovascular systems (39) 39
index medicus (35) 35
humans (34) 34
cardiology and cardiovascular medicine (25) 25
cholesterol (25) 25
abridged index medicus (24) 24
internal medicine (24) 24
female (23) 23
male (23) 23
atherosclerosis (22) 22
middle aged (22) 22
ultrasonography, interventional (18) 18
cardiovascular agents (17) 17
disease progression (17) 17
cardiovascular disease (16) 16
intravascular ultrasound (16) 16
lipids (16) 16
randomized controlled-trial (16) 16
heart attacks (15) 15
risk factors (15) 15
aged (11) 11
cardiac patients (11) 11
clinical trials (11) 11
coronary heart disease (11) 11
low density lipoproteins (11) 11
studies (11) 11
statins (10) 10
cells (9) 9
coronary artery disease - pathology (9) 9
coronary vessels (9) 9
coronary vessels - diagnostic imaging (9) 9
disease (9) 9
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (9) 9
pharmaceutical industry (9) 9
risk assessment (9) 9
triglycerides (9) 9
coronary artery disease - diagnosis (8) 8
coronary artery disease - diagnostic imaging (8) 8
development and progression (8) 8
diabetes (8) 8
follow-up studies (8) 8
low density lipoprotein (8) 8
mortality (8) 8
prevention (8) 8
therapy (8) 8
blood pressure (7) 7
predictive value of tests (7) 7
risk (7) 7
treatment outcome (7) 7
acute coronary syndromes (6) 6
cardiology (6) 6
care and treatment (6) 6
cholesterol, ldl - blood (6) 6
coronary angiography (6) 6
coronary artery disease (6) 6
coronary artery disease - blood (6) 6
coronary artery disease - drug therapy (6) 6
coronary vessels - pathology (6) 6
drug therapy (6) 6
income tax (6) 6
lipid-lowering therapy (6) 6
lipoproteins (6) 6
myocardial-infarction (6) 6
analysis (5) 5
artery-disease (5) 5
calcification (5) 5
cardiovascular events (5) 5
cardiovascular-disease (5) 5
heart-disease (5) 5
medical imaging (5) 5
progression (5) 5
prospective studies (5) 5
proteins (5) 5
acute myocardial-infarction (4) 4
atherosclerosis - diagnostic imaging (4) 4
atherosclerotic plaque (4) 4
biomarkers - blood (4) 4
c-reactive protein (4) 4
catheters (4) 4
cholesterol, hdl - blood (4) 4
coronary artery disease - complications (4) 4
coronary artery disease - metabolism (4) 4
coronary-heart-disease (4) 4
hdl (4) 4
high-risk (4) 4
hypertension (4) 4
ldl cholesterol (4) 4
medical colleges (4) 4
metaanalysis (4) 4
prognosis (4) 4
regression (4) 4
secondary prevention (4) 4
ultrasonic imaging (4) 4
adult (3) 3
angiography (3) 3
apolipoproteins (3) 3
atherosclerosis - drug therapy (3) 3
calcium (3) 3
cardiovascular diseases (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC: Cardiovascular Imaging, ISSN 1936-878X, 2016, Volume 10, Issue 4, pp. 459 - 460
Display Omitted 
Cardiovascular
Journal Article
Cardiology Clinics, ISSN 0733-8651, 05/2018, Volume 36, Issue 2, pp. 233 - 239
Type 2 diabetes is associated with elevated levels of triglycerides and small, dense low-density lipoprotein particles, in addition to low levels of... 
Clinical trials | Lipids | Diabetes | Cardiovascular risk | CARDIAC & CARDIOVASCULAR SYSTEMS | LESS-THAN-50 MG/DL | MYOCARDIAL-INFARCTION | PCSK9 INHIBITOR EVOLOCUMAB | DENSITY-LIPOPROTEIN-CHOLESTEROL | SECONDARY PREVENTION | HIGH-RISK | CARDIOVASCULAR-DISEASE | CORONARY-HEART-DISEASE | 14 RANDOMIZED-TRIALS | EICOSAPENTAENOIC ACID
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 64, Issue 9, pp. 861 - 862
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 65, Issue 13, pp. 1273 - 1282
Abstract Background Statins can regress coronary atheroma and lower clinical events. Although pre-clinical studies suggest procalcific effects of statins... 
Cardiovascular | Internal Medicine | atherosclerosis | intravascular ultrasound | calcium | statins | CARDIAC & CARDIOVASCULAR SYSTEMS | CLINICAL-TRIAL | VASCULAR CALCIFICATION | RANDOMIZED CONTROLLED-TRIAL | BEAM COMPUTED-TOMOGRAPHY | LIPID-LOWERING THERAPY | ARTERY CALCIFICATION | IN-VITRO | CALCIFIED PLAQUE BURDEN | SMOOTH-MUSCLE-CELLS | Coronary Vessels - diagnostic imaging | Plaque, Atherosclerotic - diagnostic imaging | Coronary Vessels - drug effects | Coronary Vessels - pathology | Prospective Studies | Humans | Middle Aged | Ultrasonography, Interventional | Vascular Calcification - diagnostic imaging | Male | Coronary Artery Disease - drug therapy | Vascular Calcification - drug therapy | Disease Progression | Calcium - blood | Coronary Artery Disease - diagnostic imaging | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Coronary Artery Disease - pathology | Female | Aged | Plaque, Atherosclerotic - drug therapy | Plaque, Atherosclerotic - pathology | Calcification | Pharmaceutical industry | Atherosclerotic plaque | Statins | Cardiovascular agents | Medical research | Analysis | Cardiac patients | Medicine, Experimental | Coronary heart disease | Proteins | Lipoproteins | Medical imaging | Laboratories | Coronary vessels | Atherosclerosis | Cardiovascular disease | Lipids | Triglycerides | Cholesterol
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2010, Volume 105, Issue 1, pp. 69 - 76
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2010, Volume 55, Issue 21, pp. 2399 - 2407
Objectives The aim of this study was to investigate the relationship between intravascular ultrasound (IVUS)-derived measures of atherosclerosis and... 
Cardiovascular | Internal Medicine | atherosclerosis | intravascular ultrasound | risk factors | imaging | INTIMA-MEDIA THICKNESS | REGRESSION | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | CARDIOVASCULAR EVENTS | RANDOMIZED CONTROLLED-TRIAL | LIPID-LOWERING THERAPY | PIOGLITAZONE | GLIMEPIRIDE | PROGRESSION | ARTERY-DISEASE | Multivariate Analysis | Confidence Intervals | Myocardial Infarction - mortality | Follow-Up Studies | Humans | Middle Aged | Cardiovascular Diseases - therapy | Ultrasonography, Interventional | Myocardial Revascularization - methods | Male | Myocardial Infarction - diagnostic imaging | Myocardial Infarction - therapy | Cardiovascular Diseases - diagnostic imaging | Cardiovascular Diseases - mortality | Female | Severity of Illness Index | Risk Assessment | Probability | Logistic Models | Treatment Outcome | Coronary Artery Disease - mortality | Disease Progression | Coronary Artery Disease - diagnostic imaging | Coronary Artery Disease - therapy | Survival Analysis | Aged | Myocardial Revascularization - adverse effects | Cohort Studies | Prevention | Pharmaceutical industry | Patient outcomes | Cells | Atherosclerosis | Cardiovascular agents | Studies | Confidence intervals | Heart attacks | Medical imaging | Coronary vessels | Mortality | Clinical trials | Cardiovascular disease | Lipids | Clinical outcomes | Catheters
Journal Article
American Heart Journal, ISSN 0002-8703, 2015, Volume 170, Issue 6, pp. 1061 - 1069
Background Potent pharmacologic inhibition of cholesteryl ester transferase protein by the investigational agent evacetrapib increases high-density lipoprotein... 
Cardiovascular | LIPID-LEVEL MANAGEMENT | LDL CHOLESTEROL | HDL | CARDIAC & CARDIOVASCULAR SYSTEMS | ATTENUATES ATHEROSCLEROSIS | TORCETRAPIB | CORONARY-HEART-DISEASE | CETP INHIBITION | HIGH-DENSITY-LIPOPROTEIN | TRANSGENIC MICE | ARTERY-DISEASE | Cholesterol Ester Transfer Proteins - antagonists & inhibitors | Peripheral Vascular Diseases - prevention & control | Outcome Assessment (Health Care) | Humans | Middle Aged | Male | Cerebrovascular Disorders - metabolism | Cerebrovascular Disorders - prevention & control | Peripheral Vascular Diseases - metabolism | Cholesterol, LDL - blood | Female | Double-Blind Method | Risk Assessment | Coronary Artery Disease - metabolism | Coronary Artery Disease - prevention & control | Anticholesteremic Agents - adverse effects | Peripheral Vascular Diseases - diagnosis | Cerebrovascular Disorders - diagnosis | Coronary Artery Disease - diagnosis | Anticholesteremic Agents - administration & dosage | Cholesterol, HDL - blood | Benzodiazepines - administration & dosage | Benzodiazepines - adverse effects | Drug Monitoring | Cholesterol Ester Transfer Proteins - metabolism | Low density lipoproteins | Stroke | Heart attacks | Medical imaging | Mortality | Cardiovascular disease | Lipids | Triglycerides | Family medical history | Cholesterol | Studies | Lipoproteins | Ultrasonic imaging | Atherosclerosis | Blood pressure | Research centers
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2012, Volume 5, Issue 7, pp. e21 - e23
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2010, Volume 56, Issue 21, pp. 1765 - 1765
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 65, Issue 13, pp. 1296 - 1297
  Which Path to Take at the Fork in the Road? Since Anitschkow's seminal observation of aortic atherosclerosis formation in response to feeding a... 
Cardiovascular | Internal Medicine | Cardiovascular diseases | Risk factors | Studies | Disease prevention | Lipoproteins | Heart attacks | Pathogenesis | Biomarkers | Lipids | Cardiovascular disease | Drug therapy | Cholesterol
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2016, Volume 117, Issue 9, pp. 1444 - 1448
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2013, Volume 6, Issue 8, pp. 838 - 846
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2014, Volume 114, Issue 10, pp. 1465 - 1472
Journal Article